Eric T. Ong is an Intellectual Property & Technology associate in O’Melveny’s San Francisco office. Eric focuses on patent litigation, patent analysis, and infringement cases, as well as IP counseling. He represents clients across a broad range of matters involving intellectual property and technology disputes.
Prior to joining O’Melveny, Eric practiced patent prosecution, patent litigation, and IP counseling with a global law firm.
Eric formerly worked as a research scientist for Regeneron Pharmaceuticals, where he developed platform technologies to advance drug development.
Admissions
Bar Admissions
- California
Registered to Practice
- US Patent & Trademark Office
Education
- The University of California College of Law, San Francisco, J.D.: cum laude; Senior Development Editor, UC Law Journal; CALI Awards in Patent Law, Patent Prosecution Seminar, Legal Research & Writing, Criminal Procedure
- Johns Hopkins University, M.S.E., Chemical and Biomolecular Engineering
- Johns Hopkins University, B.S., Chemical and Biomolecular Engineering
Professional Activities
Author
- “Comparison of enriched charge variants from different anti-CD3 bispecific antibodies reveals differential susceptibility of each bispecific arm to post-translational modification,” Protein Science (Mar 21, 2025).
- “Current controversy around the waiver of intellectual property rights for COVID-19 Vaccines and implications for life sciences companies,” The Life Sciences Lawyer Magazine (July 2022).
Member
- National Asian Pacific American Bar Association
Related Practices